13-methyltetradecanoic acid has been researched along with T-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, Q; Chen, K; Huang, H; Lin, T; Luo, J; Qian, D; Tian, Y | 1 |
1 other study(ies) available for 13-methyltetradecanoic acid and T-Cell Lymphoma
Article | Year |
---|---|
13-methyltetradecanoic acid exhibits anti-tumor activity on T-cell lymphomas in vitro and in vivo by down-regulating p-AKT and activating caspase-3.
Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Lymphoma, T-Cell; Mice; Mice, Nude; Myristic Acids; Neoplasm Proteins; NF-kappa B; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays | 2013 |